Primary fallopian tube carcinoma

Changed by Joshua Yap, 25 Oct 2022
Disclosures - updated 15 Jul 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Primary fallopian tube carcinoma (PFTC) isis an extremely rare malignancy that arises from the fallopian tube. They accountIt accounts for ~1 (0.2-1.1)% of all gynaecological malignancies (least common of all gynaecological malignancies 3).

Epidemiology

The estimated incidence is at ~3-4 per million women 3. It typically presents in post menopausal-menopausal females (peaks at 6th-7th decades).

Clinical presentation

Most patients are asymptomatic or tend to present with non specific-specific or insiduousinsidious symptoms. The symptoms are complex, comprising of an intermittent profuse serosanguineous vaginal discharge, colicky lower abdomino-pelvicabdominopelvic pain relieved by the vaginal discharge, and an adnexal mass can be present(present in ~15% of and). This clinical constellation is termed the Latzko triad13-14,14

Pathology

The pattern of growth can be nodular, papillary, infiltrative, or mass-forming. 

Location 

Most primary fallopian tube cancers arise from the ampulla with endoluminal growth that leads to obstruction and distension of the fallopian tube (hydrosalpinx), which explains why the majority of these patients are rarely asymptomatic in contrast with those with ovarian cancer. 

Tumours can be bilateralBilateral involvement occurs in 20~20% of the cases, mainly in advanced disease1.

The pattern of growth can be nodular, papillary, infiltrative, or mass forming. 

Recognised histological types include:

Subtypes
Location 

The tumour usually originates in the ampulla of the Fallopian tube. Bilateral involvement can in been is ~20% of cases 1.

Markers

Serum CA-125 levels are often elevated 6,8.

Radiographic features

Advanced tumours are difficult to differentiate from ovarian tumours on imaging. The presence of a hydrosalpinx can be a useful feature.

Ultrasound

While being non specific-specific, it may be sonographically identified as a complex cystic mass involving the fallopian tube with papillary projections 10-11,11

More content required

MRI

While signal characteristics are not specificnon-specific, they generally are as follows 1,3:

  • T1

    • solid tumour portion is usually of low signal 

    • if there is an associated simple serous fluid containing hydrosalpinx, this may be low signal 

    • if there is an associated simple haemorrhagic fluid containing hydrosalpinx, this may be high signal 

  • T2

    • solid tumour component is often homogeneously or heterogeneously low or of intermediate signal  

    • if there is an associated simple serous fluid containing hydrosalpinx, this may be of high signal

  • T1 C+ (Gd): solid portion often demonstrates enhancement 

Staging 

See:staging of primary fallopian tube carcinoma

Treatment and prognosis

Compared with ovarian carcinoma, fallopian tube cancer morecarcinoma tends to present at an earlier stage but has a worse prognosis, stage for stage 2. The repostedHowever, the better overall survival thereforeof fallopian tube carcinoma may be on the basis of an earlier stage at presentation 4. Treatment generally consists of surgical debulking followed by chemotherapy.

Differential diagnosis

For a mass involving the fallopian tube, differential considerations would be:

  • -<p><strong>Primary fallopian tube carcinoma (PFTC)</strong> is an extremely rare malignancy that arises from the <a href="/articles/fallopian-tube-1">fallopian tube</a>. They account for ~1 (0.2-1.1)% all gynaecological malignancies (least common of all gynaecological malignancies <sup>3</sup>).</p><h4>Epidemiology</h4><p>The estimated incidence is at ~3-4 per million women <sup>3</sup>. It typically presents in post menopausal females (peaks at 6<sup>th</sup>-7<sup>th</sup> decades).</p><h4>Clinical presentation</h4><p>Most patients are asymptomatic or tend to present with non specific or insiduous symptoms. The symptoms complex comprising of an intermittent profuse serosanguineous vaginal discharge, colicky lower abdomino-pelvic pain relieved by the vaginal discharge, and an adnexal mass can be present in ~15% of and is termed the Latzko triad<strong> </strong><sup>13-14</sup>. </p><h4>Pathology</h4><p>Most primary fallopian tube cancers arise from ampulla with endoluminal growth that leads to obstruction and distension of the fallopian tube (hydrosalpinx), which explains why the majority of these patients are rarely asymptomatic in contrast with those with ovarian cancer. </p><p>Tumours can be bilateral in 20% of the cases, mainly in advanced disease. </p><p>The pattern of growth can be nodular, papillary, infiltrative, or mass forming. </p><p>Recognised histological types include:</p><ul>
  • +<p><strong>Primary fallopian tube carcinoma </strong>is an extremely rare malignancy that arises from the <a href="/articles/fallopian-tube-1">fallopian tube</a>. It accounts for ~1 (0.2-1.1)% of all gynaecological malignancies (least common of all gynaecological malignancies <sup>3</sup>).</p><h4>Epidemiology</h4><p>The estimated incidence is at ~3-4 per million women <sup>3</sup>. It typically presents in post-menopausal females (peaks at 6<sup>th</sup>-7<sup>th</sup> decades).</p><h4>Clinical presentation</h4><p>Most patients are asymptomatic or tend to present with non-specific or insidious symptoms. The symptoms are complex, comprising of an intermittent profuse serosanguineous vaginal discharge, colicky lower abdominopelvic pain relieved by the vaginal discharge, and an adnexal mass (present in ~15%). This clinical constellation is termed the Latzko triad<strong> </strong><sup>13,14</sup>. </p><h4>Pathology</h4><p>The pattern of growth can be nodular, papillary, infiltrative, or mass-forming. </p><h5>Location </h5><p>Most primary fallopian tube cancers arise from the ampulla with endoluminal growth that leads to obstruction and distension of the fallopian tube (hydrosalpinx), which explains why the majority of these patients are rarely asymptomatic in contrast with those with ovarian cancer. </p><p>Bilateral involvement occurs in ~20% of cases, mainly in advanced disease <sup>1</sup>.</p><h5>Subtypes</h5><ul>
  • -<a href="/articles/papillary-serous-adenocarcinoma-of-fallopian-tube">papillary serous adenocarcinoma of fallopian tube</a><ul>
  • -<li>most common histological sub type</li>
  • -<li>can be histologically identical to a <a href="/articles/serous-cystadenocarcinoma-of-the-ovary">serous cystadenocarcinoma of the ovary</a>.</li>
  • +<p>papillary serous adenocarcinoma</p>
  • +<ul>
  • +<li><p>most common histological subtype</p></li>
  • +<li><p>can be histologically identical to a <a href="/articles/serous-cystadenocarcinoma-of-the-ovary">serous cystadenocarcinoma of the ovary</a></p></li>
  • -<li><a href="/articles/endometrioid-carcinoma-of-the-fallopian-tube">endometrioid carcinoma of the fallopian tube</a></li>
  • -<li><a href="/articles/transitional-cell-carcinoma-of-the-fallopian-tube">transitional cell carcinoma of the fallopian tube</a></li>
  • -</ul><h5>Location </h5><p>The tumour usually originates in the ampulla of the Fallopian tube. Bilateral involvement can in been is ~20% of cases <sup>1</sup>.</p><h5>Markers</h5><p>Serum CA-125 levels are often elevated <sup>6,8</sup>.</p><h4>Radiographic features</h4><p>Advanced tumours are difficult to differentiate from ovarian tumours on imaging. The presence of a <a href="/articles/hydrosalpinx">hydrosalpinx</a> can be a useful feature.</p><h5>Ultrasound</h5><p>While being non specific, it may be sonographically identified as a complex cystic mass involving the fallopian tube with papillary projections <sup>10-11</sup>. </p><p><em>More content required</em></p><h5>MRI</h5><p>While signal characteristics are not specific, they generally are as follows <sup>1,3</sup></p><ul>
  • +<li><p>endometrioid carcinoma</p></li>
  • +<li><p>transitional cell carcinoma</p></li>
  • +</ul><h5>Markers</h5><p>Serum <a href="/articles/ca-125" title="CA 125">CA-125</a> levels are often elevated <sup>6,8</sup>.</p><h4>Radiographic features</h4><p>Advanced tumours are difficult to differentiate from ovarian tumours on imaging. The presence of a <a href="/articles/hydrosalpinx">hydrosalpinx</a> can be a useful feature.</p><h5>Ultrasound</h5><p>While being non-specific, it may be sonographically identified as a complex cystic mass involving the fallopian tube with papillary projections <sup>10,11</sup>. </p><h5>MRI</h5><p>While signal characteristics are non-specific, they generally are as follows <sup>1,3</sup>:</p><ul>
  • -<strong>T1</strong><ul>
  • -<li>solid tumour portion is usually of low signal </li>
  • -<li>if there is an associated simple serous fluid containing hydrosalpinx this may be low signal </li>
  • -<li>if there is an associated simple haemorrhagic fluid containing hydrosalpinx this may be high signal </li>
  • +<p><strong>T1</strong></p>
  • +<ul>
  • +<li><p>solid tumour portion is usually of low signal </p></li>
  • +<li><p>if there is an associated simple serous fluid containing hydrosalpinx, this may be low signal </p></li>
  • +<li><p>if there is an associated simple haemorrhagic fluid containing hydrosalpinx, this may be high signal </p></li>
  • -<strong>T2</strong><ul>
  • -<li>solid tumour component is often homogeneously or heterogeneously low or of intermediate signal  </li>
  • -<li>if there is an associated simple serous fluid containing hydrosalpinx this may be of high signal</li>
  • +<p><strong>T2</strong></p>
  • +<ul>
  • +<li><p>solid tumour component is often homogeneously or heterogeneously low or of intermediate signal  </p></li>
  • +<li><p>if there is an associated simple serous fluid containing hydrosalpinx, this may be of high signal</p></li>
  • +<li><p><strong>T1 C+ (Gd):</strong> solid portion often demonstrates enhancement </p></li>
  • +</ul><h5>Staging </h5><p>See<strong> </strong><a href="/articles/primary-fallopian-tube-carcinoma-staging">staging of primary fallopian tube carcinoma</a></p><h4>Treatment and prognosis</h4><p>Compared with ovarian carcinoma, fallopian tube carcinoma tends to present at an earlier stage but has a worse prognosis, stage for stage <sup>2</sup>. However, the better overall survival of fallopian tube carcinoma may be on the basis of an earlier stage at presentation <sup>4</sup>. Treatment generally consists of surgical debulking followed by chemotherapy.</p><h4>Differential diagnosis</h4><p>For a mass involving the fallopian tube, differential considerations would be:</p><ul>
  • +<li><p><a href="/articles/tubal-ectopic-pregnancy">tubal ectopic pregnancy</a>: women of childbearing age and elevated β-hCG</p></li>
  • +<li><p>primary <a href="/articles/ovarian-tumours">ovarian cancer</a> (especially <a href="/articles/ovarian-epithelial-tumours">ovarian epithelial tumours</a>) with involvement of the fallopian tubes</p></li>
  • -<strong>T1 C+ (Gd):</strong> solid portion often demonstrates enhancement </li>
  • -</ul><h5>Staging </h5><p>See:<strong> </strong><a href="/articles/primary-fallopian-tube-carcinoma-staging">staging of primary fallopian tube carcinoma </a></p><h4>Treatment and prognosis</h4><p>Compared with ovarian carcinoma, fallopian tube cancer more tends to present at an earlier stage but has a worse prognosis, stage for stage <sup>2</sup>. The reposted better overall survival therefore may be on the basis of earlier stage at presentation <sup>4</sup>. Treatment generally consists of surgical debulking followed by chemotherapy.</p><h4>Differential diagnosis</h4><p>For a mass involving the fallopian tube, differential considerations would be:</p><ul>
  • -<li>
  • -<a href="/articles/tubal-ectopic-pregnancy">tubal ectopic pregnancy</a>: women of childbearing age and BHCG elevated</li>
  • -<li>primary <a href="/articles/ovarian-tumours">ovarian cancers</a> (especially <a href="/articles/ovarian-epithelial-tumours">ovarian epithelial tumours</a>) with involvement of the fallopian tubes</li>
  • -<li>infective of inflammatory conditions<ul><li>
  • -<a href="/articles/pelvic-inflammatory-disease">pelvic inflammatory disease</a> +/- <a href="/articles/pyosalpinx">pyosalpinx</a>
  • -</li></ul>
  • +<p>infective of inflammatory conditions</p>
  • +<ul><li><p><a href="/articles/pelvic-inflammatory-disease">pelvic inflammatory disease</a> +/- <a href="/articles/pyosalpinx">pyosalpinx</a></p></li></ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.